ArticleNature communications2021

Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity.

Yunqian Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.